Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q1 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Kewaunee Scientific Corp /De/ quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q1 2020 to Q2 2024.
Kewaunee Scientific Corp /De/ Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending July 31, 2024 was $43.5M, a 2.55% increase year-over-year.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$43.5M	+$1.08M	+2.55%	Jul 31, 2024	10-Q	2024-09-13
Q1 2024	$45.1M	-$1.02M	-2.21%	Apr 30, 2024	10-Q	2024-09-13
Q4 2023	$41.1M	-$2.88M	-6.55%	Jan 31, 2024	10-Q	2024-03-08
Q3 2023	$42.6M	+$1.13M	+2.72%	Oct 31, 2023	10-Q	2023-12-08
Q2 2023	$42.5M	+$1.75M	+4.29%	Jul 31, 2023	10-Q	2023-09-01
Q1 2023	$46.1M	+$4.83M	+11.7%	Apr 30, 2023	10-K	2024-06-28
Q4 2022	$44M	+$8.94M	+25.5%	Jan 31, 2023	10-Q	2023-03-10
Q3 2022	$41.5M	+$4.4M	+11.9%	Oct 31, 2022	10-Q	2022-12-09
Q2 2022	$40.7M	+$5.78M	+16.6%	Jul 31, 2022	10-Q	2022-09-09
Q1 2022	$41.3M	+$8.37M	+25.5%	Apr 30, 2022	10-K	2023-06-30
Q4 2021	$35.1M	+$4.96M	+16.5%	Jan 31, 2022	10-Q	2022-03-11
Q3 2021	$37.1M	+$3.32M	+9.82%	Oct 31, 2021	10-Q	2021-12-17
Q2 2021	$34.9M			Jul 31, 2021	10-Q	2021-09-10
Q1 2021	$32.9M	+$4.82M	+17.2%	Apr 30, 2021	10-K	2022-07-01
Q4 2020	$30.1M			Jan 31, 2021	10-Q	2021-03-12
Q3 2020	$33.8M			Oct 31, 2020	10-Q	2020-12-11
Q1 2020	$28.1M			Apr 30, 2020	10-K	2021-07-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.